Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2018 Filed May 8, 2018 23:23 UTC |
BURR ROBERT LDirector
|
GrantStock Option · Derivative | 11,500 | Not disclosed Strike: $25.24 | Not disclosed |
DisclosureSEC source: 0000899243-18-011945 · doc4.xml · derivative · entry 6 BURR ROBERT L · CIK 0001245188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Underlying: Class A Common Stock · 11,500 shares Expires 2024-05-14 F4 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F3 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:23 UTC |
BURR ROBERT LDirector
|
GrantStock Option · Derivative | 7,300 | Not disclosed Strike: $44.85 | Not disclosed |
DisclosureSEC source: 0000899243-18-011945 · doc4.xml · derivative · entry 5 BURR ROBERT L · CIK 0001245188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,300 Underlying: Class A Common Stock · 7,300 shares Expires 2025-05-12 F4 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F3 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:23 UTC |
BURR ROBERT LDirector
|
GrantStock Option · Derivative | 10,575 | Not disclosed Strike: $30.33 | Not disclosed |
DisclosureSEC source: 0000899243-18-011945 · doc4.xml · derivative · entry 4 BURR ROBERT L · CIK 0001245188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,575 Underlying: Class A Common Stock · 10,575 shares Expires 2026-05-17 F4 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F3 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:23 UTC |
BURR ROBERT LDirector
|
GrantStock Option · Derivative | 10,575 | Not disclosed Strike: $16.40 | Not disclosed |
DisclosureSEC source: 0000899243-18-011945 · doc4.xml · derivative · entry 3 BURR ROBERT L · CIK 0001245188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,575 Underlying: Class A Common Stock · 10,575 shares Expires 2027-05-16 F4 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F3 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:23 UTC |
BURR ROBERT LDirector
|
GrantClass A Common Stock | 6,057 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-011945 · doc4.xml · nonDerivative · entry 2 BURR ROBERT L · CIK 0001245188 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By the Robert L. Burr IRA Account Disclosed balance after: 6,057 F2 · price: Received in exchange for 6,057 shares of Impax common stock pursuant to the BCA. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:23 UTC |
BURR ROBERT LDirector
|
GrantClass A Common Stock | 60,475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-011945 · doc4.xml · nonDerivative · entry 1 BURR ROBERT L · CIK 0001245188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,475 F1 · price: Received in exchange for 60,475 shares of Impax Laboratories, Inc. ("Impax") common stock pursuant to the Business Combination Agreement, dated as of October 17, 2017, among Impax, Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and K2 Merger Sub Corporation (as amended, the "BCA"). Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:22 UTC |
Bisaro PaulDirector
|
GrantStock Option · Derivative | 850,000 | Not disclosed Strike: $12.70 | Not disclosed |
DisclosureSEC source: 0000899243-18-011944 · doc4.xml · derivative · entry 1 BISARO PAUL · CIK 0001237253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,000 Underlying: Class A Common Stock · 850,000 shares Expires 2027-03-27 F2 · price: Received pursuant to the Business Combination Agreement, dated as of October 17, 2017, among Impax Laboratories, Inc. ("Impax"), Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and K2 Merger Sub Corporation in exchange for an option to purchase an equal number of shares of Impax common stock. F1 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 23:22 UTC | GrantStock Option · Derivative | 52,000 | Not disclosed Strike: $17.99 | Not disclosed |
DisclosureSEC source: 0000899243-18-011942 · doc4.xml · derivative · entry 6 Reasons Bryan M. · CIK 0001553489 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Class A Common Stock · 52,000 shares Expires 2023-05-15 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
|
| May 04, 2018 Filed May 8, 2018 23:22 UTC | GrantStock Option · Derivative | 55,000 | Not disclosed Strike: $25.24 | Not disclosed |
DisclosureSEC source: 0000899243-18-011942 · doc4.xml · derivative · entry 5 Reasons Bryan M. · CIK 0001553489 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Class A Common Stock · 55,000 shares Expires 2024-05-14 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
|
| May 04, 2018 Filed May 8, 2018 23:22 UTC | GrantStock Option · Derivative | 47,500 | Not disclosed Strike: $40.70 | Not disclosed |
DisclosureSEC source: 0000899243-18-011942 · doc4.xml · derivative · entry 4 Reasons Bryan M. · CIK 0001553489 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Class A Common Stock · 47,500 shares Expires 2025-02-26 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
|
| May 04, 2018 Filed May 8, 2018 23:22 UTC | GrantStock Option · Derivative | 63,095 | Not disclosed Strike: $33.27 | Not disclosed |
DisclosureSEC source: 0000899243-18-011942 · doc4.xml · derivative · entry 3 Reasons Bryan M. · CIK 0001553489 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,095 Underlying: Class A Common Stock · 63,095 shares Expires 2026-02-26 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
|
| May 04, 2018 Filed May 8, 2018 23:22 UTC | GrantStock Option · Derivative | 56,232 | Not disclosed Strike: $9.35 | Not disclosed |
DisclosureSEC source: 0000899243-18-011942 · doc4.xml · derivative · entry 2 Reasons Bryan M. · CIK 0001553489 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,232 Underlying: Class A Common Stock · 56,232 shares Expires 2027-03-02 F3 · price: Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock. F2 · derivative.exercise_date: The option is vested and currently exercisable. Read SEC document |
|
| May 04, 2018 Filed May 8, 2018 23:22 UTC | GrantClass A Common Stock | 94,684 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-011942 · doc4.xml · nonDerivative · entry 1 Reasons Bryan M. · CIK 0001553489 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,684 F1 · price: Received in exchange for 94,684 shares of Impax Laboratories, Inc. ("Impax") common stock pursuant to the Business Combination Agreement, dated as of October 17, 2017, among Impax, Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and K2 Merger Sub Corporation (as amended, the "BCA"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.